Cargando…

Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure

ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. Recent studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villacorta, Humberto, Maisel, Alan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765013/ https://www.ncbi.nlm.nih.gov/pubmed/26761075 http://dx.doi.org/10.5935/abc.20150151

Ejemplares similares

Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone
por: Aleksova, Aneta, et al.
Publicado: (2019)

Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2
por: Wu, Alan H.B.
Publicado: (2012)

Soluble ST2 in end‐stage heart failure, before and after support with a left ventricular assist device
por: Tseng, Cheyenne C. S., et al.
Publicado: (2018)

NT-pro BNP and plasma-soluble ST2 as promising biomarkers for hypertension, hypertensive heart disease and heart failure in sub-Saharan Africa
por: Anastase, Dzudie, et al.
Publicado: (2017)

Soluble ST2 biomarker and reverse remodelling in patients with systolic heart failure
por: Yalta, Kenan, et al.
Publicado: (2018)

Cardiorenal biomarkers in acute heart failure
por: Choudhary, Rajiv, et al.
Publicado: (2012)

ST2 elevation in heart failure, predictive of a high early mortality
por: Dalal, Jamshed J., et al.
Publicado: (2018)

Hypotension and Renal Dysfunction: The Ghosts of Heart Failure
por: Villacorta Junior, Humberto, et al.
Publicado: (2017)

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022)

The role of procalcitonin in acute heart failure patients
por: Möckel, Martin, et al.
Publicado: (2017)

Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
por: Wang, Jin, et al.
Publicado: (2022)

Prognostic biomarker soluble ST2 exhibits diurnal variation in chronic heart failure patients
por: Crnko, Sandra, et al.
Publicado: (2020)

Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs
por: Teichman, Sam L., et al.
Publicado: (2015)

Biomarkers in kidney and heart disease
por: Maisel, Alan S
Publicado: (2011)

The soluble ST2 levels in patients with depression and comorbid heart failure
por: Sikora, A., et al.
Publicado: (2022)

Soluble ST2 in Heart Failure: A Clinical Role beyond B-Type Natriuretic Peptide
por: Riccardi, Mauro, et al.
Publicado: (2023)

Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
por: Grześk, Grzegorz, et al.
Publicado: (2023)

The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
por: Yang, Chaojun, et al.
Publicado: (2021)

Soluble ST2 protein in chronic heart failure is independent of traditional factors
por: Wojtczak-Soska, Karolina, et al.
Publicado: (2013)

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction – A multicenter study
por: Bahuleyan, C.G., et al.
Publicado: (2018)

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)
por: Meijers, Wouter C., et al.
Publicado: (2021)

Could Endothelin-1 Be a Promising Neurohormonal Biomarker in Acute Heart Failure?
por: Dmour, Bianca-Ana, et al.
Publicado: (2023)

The Prognostic Value of Plasma Soluble ST2 in Hospitalized Chinese Patients with Heart Failure
por: Zhang, Rongcheng, et al.
Publicado: (2014)

Soluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community‐Dwelling Population
por: Parikh, Ravi H., et al.
Publicado: (2016)

Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis
por: Lancellotti, Patrizio, et al.
Publicado: (2015)

Soluble ST2 correlates with some indicators of right ventricular function in hypertensive heart failure
por: Ojji, Dike B, et al.
Publicado: (2017)

Association of Soluble Suppression of Tumorigenesis-2 (ST2) with Endothelial Function in Patients with Ischemic Heart Failure
por: Dimitropoulos, Stathis, et al.
Publicado: (2020)

Prognostic Value of sST2 in Heart Failure
por: Sciatti, Edoardo, et al.
Publicado: (2023)

Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency
por: Kim, Min-Seok, et al.
Publicado: (2015)

New Approaches in the Management of Sudden Cardiac Death in Patients with Heart Failure—Targeting the Sympathetic Nervous System
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2019)

Soluble ST2 in predicting an adverse outcome of revascularization and the development of heart failure in patients with acute myocardial infarction with ST segment elevation
por: Kutya, I, et al.
Publicado: (2023)

Melatonin in Heart Failure: A Promising Therapeutic Strategy?
por: Nduhirabandi, Frederic, et al.
Publicado: (2018)

The power of multimodal antidepressants: decrease of soluble ST2 blood level in patients with depression and comorbid heart failure
por: Sikora, A. K., et al.
Publicado: (2023)

Association of Galectin-3 and Soluble ST2, and Their Changes, with Echocardiographic Parameters and Development of Heart Failure after ST-Segment Elevation Myocardial Infarction
por: Tymińska, Agata, et al.
Publicado: (2019)

IL‐33/ST2 pathway as upper‐hand of inflammation in allergic asthma contributes as predictive biomarker in heart failure
por: Mehrabi Nasab, Entezar, et al.
Publicado: (2022)

Myocardial Viability Testing in the Management of Ischemic Heart Failure
por: Babes, Elena Emilia, et al.
Publicado: (2022)

Biomarkers in the clinical management of patients with atrial fibrillation and heart failure
por: Koniari, Ioanna, et al.
Publicado: (2021)

Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications—A systematic review
por: Ramanathan, Kumaresan, et al.
Publicado: (2020)

Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator
por: Hou, Zhi-wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bpsk7qbi0q07973ltkb0p9ipre